Identification & Targeting of Novel Protective Disease Modifiers in ALS
Time: 2:00 pm
day: Conference Day One Track A PM
Details:
- Unpacking the role of genetic heterogeneity in ALS in drug development
- Identifying new genetic variants that show protection or slow down disease progression and extended survival in ALS
- Developing therapeutics to navigate targets in ALS
- Highlighting functional molecular rescue data – exploring heterogeneous studies
